Oncogenic B-RAF signalling in melanoma impairs the therapeutic advantage of autophagy inhibition

Armstrong, Jane, Corazzari, M, Martin, S, Pagliarini, V, Falasca, L, Hill, D S, Ellis, N, Al Sabah, S, Redfern, C P F, Fimia, G M, Piacentini, M and Lovat, P E (2011) Oncogenic B-RAF signalling in melanoma impairs the therapeutic advantage of autophagy inhibition. Clinical Cancer Research, 17 (8). pp. 2216-2226. ISSN 1078-0432

Full text not available from this repository.

Abstract

Clinical Cancer Research, 17:2216-26

Item Type: Article
Subjects: Sciences > Pharmacy and Pharmacology
Divisions: Faculty of Applied Sciences
Faculty of Applied Sciences > Department of Pharmacy Health and Wellbeing
Health Sciences and Wellbeing Beacon
Health Sciences and Wellbeing Beacon > Drug Discovery and Application Workstream
Depositing User: Glenda Young
Date Deposited: 01 Feb 2013 15:48
Last Modified: 01 Feb 2013 15:48
URI: http://sure.sunderland.ac.uk/id/eprint/3482

Actions (login required)

View Item View Item